Aktiesnakken — September 2022
-
BAVARIAN - Starter globalt i fase3 med Covid1 boostervaccine https://www.proinvestor.com/boards/105904
-
https://l.facebook.com/l.php?u=https%3A%2F%2Fnews.cision.com%2Fexpres2ion-biotechnologies%2Fr%2Ffirst-subject-vaccinated-in-covid-19-phase-iii-clinical-trial-for-abncov2-as-a-booster-vaccine%2Cc3623296%3Ffbclid%3DIwAR1FejcDA2Rxt_fqSYbWkjB5B4Jw6QSp0I02WMufU4Qe9DScZcFaAUGAuiw&h=AT2VpJ6O8qzQJMLGsaQ3S8o7IjUg-gFQHfWx16ynkxEyaQWhKr3sRojsrx95Ou8NxD4iM7oGsrJHS4-DmLE1Skpss577klEgAswB58qHJpPEIIVHoeu3cH96c_rqinjvVOBm&__tn__=R]-R&c[0]=AT3D-nDC6GTLAG07mFyDxKoSg1tPx-xx0w2XsZuEpXZoq7Lrdh5epBEDkKQwyLk3CVknUusMK
-
First subject vaccinated in COVID-19 Phase III clinical trial for ABNCoV2 as a booster vaccine
Hørsholm, Denmark, September 2, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion
News Powered by Cision (news.cision.com)
-
Godmorgen.
-
Videointerview: Helge Larsen er taget til Glostrup for at dykke ned i Hoves halvårsregnskab og tage temperaturen på business casen med CEO Maja Vonsild Jørgensen https://www.proinvestor.com/boards/105912
-
Nasdaq Bear Market: 5 Incomparable Growth Stocks You'll Regret Not Buying On the Dip
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind